Stryker Stock Performance
| SYK Stock | USD 396.66 4.27 1.07% |
Stryker has a performance score of 11 on a scale of 0 to 100. The entity has a beta of 0.89, which indicates possible diversification benefits within a given portfolio. Stryker returns are very sensitive to returns on the market. As the market goes up or down, Stryker is expected to follow. Stryker right now has a risk of 0.94%. Please validate Stryker total risk alpha, downside variance, as well as the relationship between the Downside Variance and daily balance of power , to decide if Stryker will be following its existing price patterns.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Stryker are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain basic indicators, Stryker may actually be approaching a critical reversion point that can send shares even higher in August 2025. ...more
Actual Historical Performance (%)
One Day Return 1.46 | Five Day Return 2.5 | Year To Date Return 11.77 | Ten Year Return 308.07 | All Time Return 481 K |
Forward Dividend Yield 0.0087 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 3.36 | Dividend Date 2025-07-31 |
| Stryker dividend paid on 30th of April 2025 | 04/30/2025 |
1 | Linden Thomas Advisory Services LLC Purchases 485 Shares of Stryker Corporation | 07/09/2025 |
2 | Stryker Sales secures 450M modification from Defense Logistics Agency | 07/14/2025 |
3 | Disposition of 102 shares by M Fink of Stryker subject to Rule 16b-3 | 07/15/2025 |
4 | Dows JJ Surges Why Its Report Is Also Bullish For Stryker, Medtronic, Boston Scientific | 07/16/2025 |
5 | Stryker Corporation Shares Sold by Massachusetts Financial Services Co. MA | 07/17/2025 |
6 | 2 Unpopular Stocks That Should Get More Attention and 1 We Ignore | 07/21/2025 |
7 | Microbot Medical Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales | 07/22/2025 |
| Begin Period Cash Flow | 3 B | |
| Total Cashflows From Investing Activities | -3 B |
Stryker Relative Risk vs. Return Landscape
If you would invest 36,428 in Stryker on April 25, 2025 and sell it today you would earn a total of 3,238 from holding Stryker or generate 8.89% return on investment over 90 days. Stryker is generating 0.1418% of daily returns assuming volatility of 0.9377% on return distribution over 90 days investment horizon. In other words, 8% of stocks are less volatile than Stryker, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Stryker Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stryker's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Stryker, and traders can use it to determine the average amount a Stryker's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1512
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | SYK | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 0.94 actual daily | 8 92% of assets are more volatile |
Expected Return
| 0.14 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Stryker is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Stryker by adding it to a well-diversified portfolio.
Stryker Fundamentals Growth
Stryker Stock prices reflect investors' perceptions of the future prospects and financial health of Stryker, and Stryker fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Stryker Stock performance.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0749 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 165.38 B | ||||
| Shares Outstanding | 382.16 M | ||||
| Price To Earning | 63.07 X | ||||
| Price To Book | 7.07 X | ||||
| Price To Sales | 6.50 X | ||||
| Revenue | 22.59 B | ||||
| Gross Profit | 15.02 B | ||||
| EBITDA | 5.72 B | ||||
| Net Income | 2.99 B | ||||
| Cash And Equivalents | 3.65 B | ||||
| Cash Per Share | 2.98 X | ||||
| Total Debt | 1.41 B | ||||
| Debt To Equity | 0.88 % | ||||
| Current Ratio | 2.00 X | ||||
| Book Value Per Share | 54.77 X | ||||
| Cash Flow From Operations | 4.24 B | ||||
| Earnings Per Share | 7.39 X | ||||
| Market Capitalization | 151.01 B | ||||
| Total Asset | 42.97 B | ||||
| Retained Earnings | 18.53 B | ||||
| Working Capital | 7.23 B | ||||
| Current Asset | 1.15 B | ||||
| Current Liabilities | 707.5 M | ||||
About Stryker Performance
By examining Stryker's fundamental ratios, stakeholders can obtain critical insights into Stryker's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Stryker is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 213.67 | 146.53 | |
| Return On Tangible Assets | 0.13 | 0.10 | |
| Return On Capital Employed | 0.10 | 0.10 | |
| Return On Assets | 0.07 | 0.11 | |
| Return On Equity | 0.15 | 0.19 |
Things to note about Stryker performance evaluation
Checking the ongoing alerts about Stryker for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Stryker help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 81.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Microbot Medical Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales |
- Analyzing Stryker's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Stryker's stock is overvalued or undervalued compared to its peers.
- Examining Stryker's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Stryker's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Stryker's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Stryker's stock. These opinions can provide insight into Stryker's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.18) | Dividend Share 3.28 | Earnings Share 7.39 | Revenue Per Share | Quarterly Revenue Growth 0.119 |
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.